ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Allograft Parenchymal Cell Expression of Tlr9 is Required for Endogenous Donor-Reactive Memory Cd8 T Cell Activation within High-Risk Cardiac Allografts to Mediate Ctla-4 Ig Resistant Graft Rejection

D. Ueda, H. Tsuda, S. Miyairi, R. L. Fairchild

Lerner Reserch Institute, Cleveland Clinic, Cleveland, OH

Meeting: 2020 American Transplant Congress

Abstract number: 635

Keywords: Inflammation, Ischemia, Tolerance

Session Information

Date: Saturday, May 30, 2020

Session Name: Innate Immunity; Chemokines, Cytokines, Complement

Session Time: 3:15pm-4:45pm

 Presentation Time: 4:03pm-4:15pm

Location: Virtual

Related Abstracts
  • Graft Dendritic Cell p40 Homodimers Activate Donor-Reactive Endogenous Memory CD8 T Cells within Higher Risk Allografts
  • p40 Homodimers Indirectly Induce Endogenous Donor-Reactive Memory CD8 T Cell Activation within High-Risk Cardiac Allografts and CTLA-4ig Resistant Graft Rejection via IL-15 Signaling

*Purpose: Increased ischemia-reperfusion graft inflammation provokes activation of endogenous donor-reactive memory CD8 T cells within complete MHC-mismatched cardiac allografts at 24 hrs after graft reperfusion to express effector functions that mediate CTLA-4Ig-resistant graft rejection.

*Methods: The current study tested the role of TLR signaling for the innate immune induction of this endogenous donor-reactive memory CD8 T cell response in “high-risk” cardiac allografts subjected to prolonged cold-ischemic storage (CIS) prior to transplant.

*Results: High-risk TLR4-/- allografts did not compromise memory CD8 T cell activation or CTLA-4Ig resistant rejection observed in wild type (WT) allografts. When RNA from WT allografts subjected to 0.5 vs. 8 hrs CIS was interrogated 48 hrs after transplant, expression of TLR9, but not TLR4 or TLR7, was increased >3-fold in the high-risk grafts. In contrast to WT C57BL/6 allografts, unsensitized BALB/c recipient endogenous memory CD8 T cell activation within high-risk B6.TLR9-/- allografts was virtually absent and recipient conditioning with CTLA-4Ig prolonged allograft survival to a median of 44 days vs. 27 days for high-risk WT allografts. High-risk WT B6 and B6.TLR9-deficient allografts were rejected at the same time (day 8-9) in untreated BALB/c recipients and numbers of donor-reactive T cells producing IFN-γ were the same in the spleens of both recipients, indicating that the presence or absence of TLR9 did not impact the activation of the de novo donor-reactive response. Reciprocal wild type and TLR9-/- radiation-induced/bone marrow reconstituted chimeras were generated for use as donors of cardiac allografts subjected to 8 hrs CIS prior to transplant. High risk cardiac allografts from TLR9 bone marrow to WT chimeras had a median survival time of 28.5 days in CTLA-4Ig conditioned BALB/c recipients (CTLA-4Ig resistant rejection is maintained when TLR9-deficiency is restricted to graft bone marrow-derived cells) whereas allografts from WT bone marrow reconstituted TLR9-/- recipient chimeras survived with a median of 110 days (CTLA-4Ig resistant rejection is abrogated when TLR9-deficiency is restricted to graft non-bone marrow-derived cells).

*Conclusions: These results indicate that TLR9 signaling on parenchymal cells in allografts subjected to prolonged CIS prior to transplant is required for endogenous donor-reactive memory CD8 T cell activation to mediate CTLA-4 resistant rejection.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ueda D, Tsuda H, Miyairi S, Fairchild RL. Allograft Parenchymal Cell Expression of Tlr9 is Required for Endogenous Donor-Reactive Memory Cd8 T Cell Activation within High-Risk Cardiac Allografts to Mediate Ctla-4 Ig Resistant Graft Rejection [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/allograft-parenchymal-cell-expression-of-tlr9-is-required-for-endogenous-donor-reactive-memory-cd8-t-cell-activation-within-high-risk-cardiac-allografts-to-mediate-ctla-4-ig-resistant-graft-rejection/. Accessed March 3, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.